国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Application of New Biotechnologies for Prostate Cancer Treatment (Comparative Analysis of Brachytherapy, Cryosurgery, Laparoscopy, Robotic Arm and Cyberknife Methods)

Giuseppe Morgia, Chaled Alnakib and Giorgio Ivan Russo

Prostate cancer is the second most commonly diagnosed non-dermatologic malignancy among American men and the 6th most fatal cancer worldwide. Open field radical prostatectomy is the gold standard procedure for treatment of prostate cancer. Yet, several novel methodologies have been emerging lately, promising to be mini-invasive, to reduce complications related to surgery and to offer the patient a better quality of life thereafter. Among the latter, preservation of urinary and sexual function appear to be the most important. Some of such alternative treatments may be found applicable to patients with a life expectancy less than 10 years, or those unfit for surgery for other reasons. The present manuscript has been aimed to overview the most prominent novel methods for prostate cancer treatment, in attempt to point out the options and the rationale for choosing a method, or a combination of methods, for the best and the most effective treatment of prostate cancer.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。